You Are Right to Own This Stock

Recs

34

"Here's a little tip most Wall Street types would prefer you not know: The recipe for great long-run success in the stock market is startlingly simple.

You heard me
You might find that hard to believe, given the market's recent tumults -- not to mention studies that have shown most mutual fund managers underperform the market. Still, it is true. Empirical research from professors Eugene Fama and Kenneth French, along with that of Jeremy Siegel, supports the notion that excess returns are there for the taking for those who look for value-priced stocks.

But scholarly research is one thing. Application is another. If you're looking for a real-life example of the power of taking a long-run, value-focused approach to investing, look no further than the jaw-dropping success of one of the world's richest men, Warren Buffett.

How it works
This proven process for beating the market is actually pretty straightforward. Here's how it works:

  1. Buy great businesses.
  2. Buy them cheap.
  3. Be patient ... but bold.

Want more color? Let's dance.

1. Buy great businesses
Businesses with quality management and durable competitive advantages (a.k.a. economic moats) drive supreme long-run value for their investors. These competitive advantages allow companies to consistently earn returns in excess of their cost of capital, helping to fund growth, share repurchases, and dividend hikes -- and, of course, boosting share prices. Put simply, moats make money.

Durable competitive advantages come in several forms. A few of the most valuable and well-known are:

  • Network effects -- think UPS (NYSE: UPS) or FedEx (NYSE: FDX).
  • Cost advantages -- think ExxonMobil (NYSE: XOM) or McCormick & Co. (NYSE: MKC).
  • Intellectual property -- think Merck (NYSE: MRK).
  • High switching costs -- think UnitedHealth Group (NYSE: UNH) or Intuitive Surgical (Nasdaq: ISRG).

A quick way to judge whether a company has a durable competitive advantage is to look at its historical returns on invested capital. If they're consistently strong (generally speaking, higher than 13%), you're probably looking at a strong business.

2. Buy them cheap
Finding great businesses takes you a long way toward market-beating returns. But there's just one problem: Great businesses rarely look cheap by traditional metrics. Let's look at some of the top-performing S&P 500 stocks from 1957 to 2003, according to the work of Jeremy Siegel:

Company

Annual Return

Average P/E

Altria

19.8%

13.1

Abbott Laboratories

16.5%

21.4

Bristol-Myers Squibb

16.4%

23.5

Tootsie Roll

16.1%

16.8

Merck

15.9%

25.3

S&P 500

10.9%

17.5

Source: Jeremy Siegel, The Future for Investors.

As the last column suggests, great businesses almost always look a bit pricey. What should investors do, then?

In the order of operations, finding a great company is first and foremost. Once you've identified said company, keep an eye on it until it comes down to at least a good price -- because it is possible to turn a good company into a bad investment.

Coca-Cola, for example, rarely looks cheap. But when the shares were beaten down in 1988, Buffett backed up the truck for the wide-moat beverage giant, making a killing in the process. To quote Roger Lowenstein's Buffett biography:

By the latter part of 1988, Coca-Cola was trading at 13 times expected 1989 earnings, or about 15% above the average stock. That was more than a Ben Graham would have paid. But given its earning power, Buffett thought he was getting a Mercedes for the price of a Chevrolet.

Great company, good price. Buffett has built a fortune using that simple rule.

3. Be patient ... but bold
As I said earlier, great businesses don't often fall into the realm of cheap. When the rare fat pitch does cross your plate, though, don't be afraid to take a hard swing at it. Now, you might be thinking "That's great that Mr. Buffett was able to cash in on Coke 20 years ago, but pitches that fat just don't come along very often."

Au contraire, my friend. Bear markets such as this one, where investors are shouting doom and gloom from the rooftops, are a perfect time to find great businesses at cheap prices.

Case in point? Recent Inside Value rerecommendation American Express. Shares of this wide-moat gem have been hovering around generational lows, thanks to consumer weakness and the market's cold feet regarding anything even remotely tied to financials or consumers. Amex won't rocket up the charts overnight, but for patient investors who are willing to go against the grain and grab shares right now, the long-run return prospects look incredibly favorable.

If you currently have a position in American Express, you are right to own this stock -- it's a great business trading for a great price. (And not coincidentally, Buffett is a longtime shareholder.)

So is value investing right for you?
Buffett-style value investing isn't right for everyone. Even if you're willing to take the time to identify outstanding companies with lasting competitive advantages, only a unique individual can confidently stroll into a market when peers are running for the exits.

Still, for those with the dedication and the right temperament, the intrinsic and financial rewards can be substantial.

With the Fool's Inside Value newsletter service, members receive two new investment ideas each month, along with continuing coverage of all past recommendations. You can find out the team's top five stocks for new money right now by signing up for a 30-day free trial.

This article was first published on Aug. 5, 2008. It has been updated.

Joe Magyer does not own shares of any company mentioned. The Motley Fool owns shares of American Express and UnitedHealth Group. Coca-Cola, UnitedHealth Group, and American Express are Inside Value recommendations. UPS is an Income Investor recommendation, FedEx is a Stock Advisor recommendation, and Intuitive Surgical is a Rule Breakers recommendation. Whew. The Motley Fool has a disclosure policy.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On January 14, 2009, at 7:23 PM, PauvrePapillon wrote:

    How about this one?

    Here is a multi-bagger in the making, flying well under the Wall Street radar, that has a truly disruptive and revolutionary technology.

    http://www.accuray.com

    From Breakthroughs That Will Change Lives in 2009…

    “Cyberknife has the potential to replace surgery as the first form of treatment for cancer,” says Dr Nick Plowman, director of clinical oncology at St Bartholomew's Hospital.

    http://www.dailymail.co.uk/health/article-1106224/From-machi...

    And it’s just now being discovered by, and moving into, a huge market…

    From Is CyberKnife Ready for Prime Time in Prostate Cancer?

    “You are able to give very high doses and sculpt those doses to the tumor,” said Omar Dawood of Accuray Inc. in Sunnyvale, Calif., which has installed more than 90 systems in the United States as doctors have started using the machine for other cancers. “It could revolutionize the way prostate cancer is treated.”

    http://blogs.wsj.com/health/2008/11/28/is-cyberknife-ready-f...

    CAPS All-Stars like it…

    http://caps.fool.com/Ticker/ARAY.aspx

    And it’s making waves in Europe and Asia as well…

    From ABC News London…

    http://www.abcnews.go.com/Video/playerIndex?id=6549791

    You might also note that since 6 December 2008, when Accuray released two animated videos (on their website) that demonstrate what CyberKnife is and why it is different from gantry-mounted radiation sprayers, their shares have gained 32 percent (as of close of market today) while Varian has lost 9.5 percent, Tomo has lost 27 percent and the NASDAQ is down 1.3 percent.

Add your comment.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 810315, ~/Articles/ArticleHandler.aspx, 11/9/2009 2:15:03 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Which Companies Can Buy It Like Buffett?

Related Tickers

11/6/2009 4:01 PM
MKC $35.06 Up +0.04 +0.11%
McCormick & Compan… CAPS Rating: ****
FDX $77.12 Up +2.12 +2.83%
FedEx Corp CAPS Rating: ***
ISRG $256.00 Down -3.91 -1.50%
Intuitive Surgical… CAPS Rating: ****
XOM $72.58 Up +0.08 +0.11%
ExxonMobil Corp CAPS Rating: ****
MRK $32.59 Down -0.12 -0.37%
Merck & Co., Inc. CAPS Rating: ****
UNH $28.67 Up +0.46 +1.63%
UnitedHealth Group… CAPS Rating: *****
UPS $54.86 Up +0.40 +0.73%
United Parcel Serv… CAPS Rating: ***

Community: Investing Wiki

Term Of The Hour

Speculation: Speculation is a risky bet that could have a large payoff if it works out. The speculative investor attempts to profit from the price fluctuations of real estate, commodities, stocks, or any other type of investment that stands to churn out a profit.

Want to learn more or edit this definition?
Click here to read more!